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Upon systemic infection with human pathogenic yeast Candida albicans (C. albicans), 
human monocytes and polymorph nuclear neutrophilic granulocytes are the first immune 
cells to respond and come into contact with C. albicans. Monocytes exert immediate 
candidacidal activity and inhibit germination, mediate phagocytosis, and kill fungal cells. 
Here, we show that human monocytes spontaneously respond to C. albicans cells 
via phagocytosis, decondensation of nuclear DNA, and release of this decondensed 
DNA in the form of extracellular traps (called monocytic extracellular traps: MoETs). 
Both subtypes of monocytes (CD14++CD16−/CD14+CD16+) formed MoETs within the 
first hours upon contact with C. albicans. MoETs were characterized by the presence 
of citrullinated histone, myeloperoxidase, lactoferrin, and elastase. MoETs were also 
formed in response to Staphylococcus aureus and Escherichia coli, indicating a general 
reaction of monocytes to infectious microbes. MoET induction differs from extracellular 
trap formation in macrophages as MoETs are not triggered by simvastatin, an inhibitor 
of cholesterol synthesis and inducer of extracellular traps in macrophages. Extracellular 
traps from both monocytes and neutrophils activate complement and C3b is deposited. 
However, factor H (FH) binds via C3b to the extracellular DNA, mediates cofactor activity, 
and inhibits the induction of the inflammatory cytokine interleukin-1 beta in monocytes. 
Altogether, the results show that human monocytes release extracellular DNA traps in 
response to C. albicans and that these traps finally bind FH via C3b to presumably 
support clearance without further inflammation.
Keywords: Candida, monocytes, Dna traps, MPO, factor h
Abbreviations: MoET, monocytic extracellular trap; E, elastase; MPO, myeloperoxidase; LAC, lactoferrin; cit H3, citrullinated 
histone 3; NET, neutrophil extracellular trap; FH, factor H; IL-1β, interleukin-1 beta.
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inTrODUcTiOn
Candida spp. are common pathogens in hospital-acquired infec-
tions and are the fourth most common cause of nosocomial 
bloodstream infections (1). Among clinical cases of fungal 
infections, the most frequently isolated human fungal pathogen 
is Candida albicans (C. albicans). This dimorphic human fungus 
often causes systemic life-threatening infections, particularly 
in immunocompromised individuals (2, 3). Despite currently 
available antifungal therapies, C. albicans-associated mortality 
and morbidity remain high (4), and more than 50% of infected 
patients die due to systemic candidemia (5, 6). Understanding the 
biology of the infection process and pathogenicity of C. albicans 
will help to find efficient therapies.
Invading fungal cells are immediately attacked by the human 
innate immune system, which involves the activated complement 
system, generation of antimicrobial peptides, and stimulation 
of immune cells. All three complement pathways, the classical, 
alternative, and lectin pathways, are activated by C. albicans 
(7–9). The relevance of complement activation for the immune 
response against C. albicans is demonstrated by infection of 
C3- and C5-knockout mice, which show increased mortality as 
a consequence of impaired anti-Candida response and infection-
driven immunopathology (10, 11). Induction of the major effec-
tor mechanisms in neutrophils was recently demonstrated to be 
directly dependent on the complement system (12).
In addition, phagocytic and epithelial cells of the innate 
immune system recognize C. albicans. These cells express phylo-
genetically conserved receptors such as the complement, toll-like, 
and lectin receptors that bind to pathogen-associated molecular 
patterns and support phagocytosis and production of pro-inflam-
matory cytokines and chemokines (13, 14). Among these phago-
cytic cells, monocytes immediately traffic to sites of C. albicans 
infection, exerting significant candidacidal activity (15). Both 
classes of monocytes, classical CD14++CD16− and non-classical 
CD14+CD16+ human blood monocytes, exert candidacidal activ-
ity, such as inhibition of germination, phagocytosis, and killing 
(16). The contribution of monocytes to immune defense was con-
firmed by in vivo studies using mice with depleted mononuclear 
phagocytes. These mice show accelerated fungal proliferation in 
tissues and increased mortality (15). The important contribution 
of monocytes to the innate immune control of infections in blood 
has been less recognized (17), and candidacidal activity upon first 
contact remained largely uncharacterized.
Interestingly, monocytes do not substantially contribute to 
most tissue macrophage populations in the steady state or during 
certain types of inflammation (18). Instead, they are considered 
to represent precursors of peripheral mononuclear phagocytes 
with the central functions of uptake of microbes and induction 
of cytokines. However, monocytes are besides neutrophils the 
first cells that come into contact with microbes in the blood 
and may have additional functions in innate immunity. In this 
study, we show how monocytes exert their early anti-fungicidal 
activities, which include phagocytosis of the microbe, generation 
of myeloperoxidase (MPO) to attack the pathogen, and forma-
tion of extracellular DNA traps to restrict dissemination of the 
fungus. Extracellular DNA in form of monocytic extracellular 
traps (MoETs) from monocytes or neutrophil extracellular traps 
(NETs) from neutrophils activates complement and C3b deposits 
onto MoETs and NETs. Interestingly, complement factor H (FH) 
binds via C3b to the extracellular DNA, retains cofactor activity 
for factor I, and restricts complement activation as well as further 
inflammation.
MaTerials anD MeThODs
cells
Monocytes were isolated from fresh sterile buffy coats (Jena 
University Hospital, Germany) or from fresh blood collected from 
healthy volunteers after informed consent according to guidelines 
from the local ethics committee. The study was conducted in 
accordance with the Declaration of Helsinki, all the protocols 
were approved by the Ethics Committee of the Jena University 
Hospital. Human PBMCs were isolated by Ficoll-Paque PLUS 
(GE healthcare, Freiburg, Germany) (density 1.077 g/ml) density 
gradient centrifugation. Lymphocytes were removed from the 
isolated PBMCs using 46% Percoll (GE healthcare, Freiburg, 
Germany) density gradient centrifugation. Monocytes were fur-
ther purified according the manufacturer’s protocol provided with 
pan monocyte isolation kit (Miltenyi Biotec, Teterow, Germany). 
Isolated monocytes were suspended in growth medium (RPMI 
medium supplemented with 10% heat-inactivated FCS and 
2 mM ultra glutamine 1) and used for experiments within 1 h. 
Purity of isolated cells was confirmed by identifying CD14 (FITC 
anti-human CD14 antibody, Biolegend, London, UK) on the cells 
using flow cytometry.
Monocytic cells THP-1 (ATCC 16, Manassas, VA, USA) 
were maintained in growth medium at 37°C and 5% CO2. Cells 
were passaged every 2 days and used for experiments until 30th 
passage. Complement active human serum was prepared from 
fresh whole blood, which was immediately centrifuged (10 min, 
13,200 rpm, 4°C) mixed in a pooled stock and stored in aliquots 
at −80°C.
Microbial strains and culture
Candida albicans wild type (SC5314) (19) and GFP-expressing 
C. albicans (20) were grown overnight in yeast extract–peptone–
dextrose medium (2% d-glucose, 1% peptone, 5% yeast extract 
in water) at 30°C, reseeded in yeast–peptone–dextrose medium, 
grown for 4  h at 30°C into the midlog-phase. Staphylococcus 
aureus (USA 300 LAC) and Escherichia coli (XL1-Blue) were 
grown overnight in tryptic soy broth and Luria–Bertani broth at 
37°C, reseeded in same broth and grown until OD 1 at 37°C into 
the midlog-phase.
Phagocytosis assay
GFP-expressing C. albicans (5 × 106) were added to monocytes 
(5 × 105) in a 24-well plate in growth medium or in growth medium 
with complement active normal human serum (NHS, 10%). 
Monocytes were pre-stained with Vybrant DiD Cell-Labeling 
solution (5 µM) (Thermo Fisher Scientific, Dreieich, Germany). 
After 0–2  h of coincubation at 37°C with 5% CO2, C. albicans 
were collected by removing the supernatant and monocytes were 
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collected by detachment of cells using accutase (GE healthcare, 
Freiburg, Germany). Phagocytosis of C. albicans by monocytes 
was analyzed by flow cytometry. In parallel, C. albicans cells were 
labeled with mouse monoclonal Pra1 antibodies, and phagocy-
tosis was measured as described above. Monoclonal antibodies 
(mAb) were generated by standard methods and specificity of the 
mAb was confirmed by Western blotting (data not shown).
Microscopy
Live Cell Imaging
Monocytes (2 × 105) were seeded on Poly-l-lysine coated 30 mm 
culture dishes and incubated in growth medium with 10% 
NHS at 37°C with 5% CO2. C. albicans wild type (SC5314) or 
GFP-expressing C. albicans (each 2 ×  105) were added to the 
seeded cells. For detection of phagocytosis, monocytes were 
pre-stained with Vybrant DiD Cell-Labeling solution (5  µM) 
and DNA release was detected with nucleic acid dye SYTOX blue 
(Thermo Fisher Scientific, Dreieich, Germany) (5  µM) during 
coincubation. Monocyte subgroups were detected with Alexa 
Fluor 488 labeled anti-human CD14 antibody (1:100) and Alexa 
Fluor 647 labeled anti-human CD16 antibody (each 1:100) (both 
Biolegend, London, UK). Monocytes were co-incubated in small 
culture dishes at 37°C with 5% CO2 and subjected to confocal 
laser scanning microscopy (LSM 710 from Carl Zeiss, Jena, 
Germany). Live time images were captured over 6 h taking images 
every 30 s using ZEN 2011 (magnification 40×, 444/480 nm for 
SYTOX blue, 488/509 nm for GFP, 488/525 nm for Alexa Fluor 
488, 594/633 nm for Alexa Fluor 647, and 650/670 nm for DiD 
dye). The experiments were repeated two to seven times.
Fixed Cell Imaging
Candida albicans wild type (SC5314) or Calcofluor-white stained 
(Sigma-Aldrich, Taufkirchen, Germany) C. albicans wild type 
(SC5314) were added to monocytes (5 × 105) on 13 mm Poly-
l-lysine coated coverslips in a 24-well plate in growth medium 
with 10% NHS. Monocytes were also incubated with 50 µg/ml 
whole glucan particles (WGP) (Invivogen, San Diego, CA, USA) 
or 20 ng/ml LPS (Sigma-Aldrich, Taufkirchen, Germany). Upon 
co-incubating monocytes with C. albicans or WGP or LPS for 4 h 
at 37°C in 5% CO2, media were aspirated, and reaction was fixed 
using 4% paraformaldehyde (PFA) for 10 min. For degradation of 
MoETs, probes were treated with 10 U/ml of DNAse-1 (Thermo 
Fisher Scientific, Dreieich, Germany) for 30 min before adding 
4% PFA. After treatment with PFA, coverslips were stained with 
5 µM SYTOX green for the detection of MoETs or coverslips were 
blocked for 1 h in 10% FCS, 1% BSA, and 0.1% Tween 20 in PBS. 
Cit-H3 on MoETs was detected by incubating the probes for 1 h 
with rabbit anti-histone H3 (citrulline R2 + R8 + R17) antibody 
(Abcam, Cambridge, UK) (1:1,000) followed by Alexa Fluor 647 
conjugated anti-rabbit IgG (H + L) secondary antibody (Thermo 
Fisher Scientific, Dreieich, Germany) (1:2,000) and SYTOX green 
(5 µM). MPO was detected with mouse anti-human MPO anti-
body (Biolegend, London, UK) (1:500), elastase with mouse anti-
human elastase (AbD Serotec, Puchheim, Germany) (1:500), and 
lactoferrin (LAC) with mouse anti-human LAC (AbD Serotec, 
Puchheim, Germany) (1:500) antibodies all followed by staining 
with Alexa Fluor 647 labeled anti-mouse IgG (H + L) second-
ary antibody (Thermo Fisher Scientific, Dreieich, Germany) 
(1:2,000) and SYTOX green (5  µM). CD14 on MoETs was 
detected by incubating the probes for 1 h with Alexa Fluor 488 
anti-human CD14 Antibody (1:100) and SYTOX orange (5 µM) 
(Thermo Fisher Scientific, Dreieich, Germany). C3b on MoETs 
and NETs was detected using rabbit anti-human complement 
C3d antibody (Dako, Hamburg, Germany) (1:100) and C5b–9 
on MoETs was detected using rabbit anti-human Complement 
SC5b–9 neoantigen antiserum (Comptech, TX, USA) (1:100) 
then followed by staining with Alexa Fluor 647 conjugated anti-
rabbit IgG (H + L) secondary antibody (Thermo Fisher Scientific, 
Dreieich, Germany) (1:2,000) and SYTOX green (5 µM). FH on 
MoETs and NETs was detected using goat anti-human FH anti 
serum (Comptech, TX, USA) (1:100) followed by staining with 
Alexa Fluor 647 conjugated with anti-goat IgG (H + L) secondary 
antibody (Thermo Fisher Scientific, Dreieich, Germany) (1:2,000) 
and SYTOX green (5 µM). Images were captured using LSM 710 
equipped with ZEN 2011 (355/433  nm for Calcofluor-white, 
488/525 nm for Alexa Fluor 488, 504/523 nm for SYTOX green, 
547/570 nm for SYTOX orange, and 594/633 nm for Alexa Fluor 
647). MoETs from monocytes were similarly detected in presence 
of S. aureus (USA 300 LAC) and E. coli (XL1-Blue) with a MOI of 
1:10. The experiments were repeated three to five times.
Electron Microscopy
Monocytes (5 × 105) alone or monocytes (5 × 105) with C. albicans 
wild type (SC5314) (5 × 105) were added to a 12 mm Poly-l-lysine 
coated coverslips placed in a 24-well plate in growth medium 
with 10% NHS. After 4 h of coincubation at 37°C with 5% CO2, 
media were aspirated, and reaction was pre-fixed for 1 h using 
2.5% glutaraldehyde in sodium cacodylate buffer (0.1 M, pH 7.0). 
The samples were washed with cacodylate buffer and post-fixed 
for 1 h with 1% osmium tetroxyde in cacodylate buffer. Samples 
were dehydrated in rising ethanol concentrations followed by 
critical point drying in a Leica EM CPD300 Automated Critical 
Point Dryer (Leica, Wetzlar, Germany) and finally coated with 
platinum (6 nm) in a BAL-TEC MED 020 Sputter Coating System 
(BAL-TEC, Balzers, Liechtenstein). The samples were imaged at 
different magnifications with a Zeiss-LEO 1530 Gemini field 
emission scanning electron microscope (Carl Zeiss, Oberkochen, 
Germany) at 7 kV acceleration voltage and a working distance of 
7 mm using an intense secondary electron detector. The experi-
ment was repeated three times.
Dna Quantification assay
Previously described procedure was followed for this quantifica-
tion (21). Shortly, monocytes (105  cells/well) were seeded into 
96-well black plates. For coincubation, C. albicans (5 × 105 cells/
well) was added to each well at a MOI of 1:5 in growth medium 
alone or in growth medium with 10% NHS or with 10% heat-
inactivated NHS (56°C for 1 h). No C. albicans was seeded for 
control monocytes. SYTOX green (5 µM) was added to all probes 
and incubated at 37°C with 5% CO2. DNA release and ROS 
formation was quantified by measuring fluorescence intensity of 
SYTOX green (485/538 nm) every hour using a Safire plate reader 
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(Tecan, Männedorf, Switzerland) and subtracting the values of 
fluorescence intensity of control monocyte. Similarly, DNA was 
quantified from neutrophils. The experiments were repeated 
three to four times.
isolation of extracellular Traps
Extracellular traps from monocytes were isolated according to 
a modified protocol by Barrientos et al. (22). Briefly, monocytes 
(1.5 × 106) were seeded into 12-well plates and incubated with 
C. albicans cells (7.5 × 106) in growth medium with 10% NHS for 
4 h at 37°C and 5% CO2. Monocytes alone were used as controls. 
Following 4 h incubation period, the wells were washed twice by 
DPBS, and probes were incubated with AluI (4 U/ml) (Thermo 
Fisher Scientific, Dreieich, Germany) for 20 min at 37°C to digest 
the extracellular traps into fragments. The supernatants were 
harvested by centrifugation (10,000 rpm for 5 min at 4°C) and 
the amount of extracellular DNA was quantified after staining 
with SYTOX green (5 µM). For standardization, Lambda DNA 
(Thermo Fisher Scientific, Dreieich, Germany) was similarly 
stained and measured (485/538 nm). Neutrophils were incubated 
with C. albicans or 100  nM phorbol 12-myristate 13-acetate 
(PMA) (Sigma-Aldrich, Taufkirchen, Germany) in growth 
medium and extracellular traps were isolated. Presence of citrul-
linated H3 was also assessed by Western blot analysis of isolated 
MoETs using rabbit anti-histone H3 (citrulline R2 + R8 + R17) 
antibody (Abcam, Cambridge, UK) (1:1,000) and polyclonal goat 
anti-rabbit antibody/HRP (Dako, Hamburg, Germany) (1:2,000).
antifungal assay
Freshly cultured wild-type C. albicans cells (5  ×  103) were 
incubated with 50 ng of isolated MoET DNA or 50 ng of THP-1 
chromosomal DNA or 50  ng of monocyte chromosomal DNA 
in growth medium at 37°C for 30 h inside Spectra Max 190 plate 
reader. Chromosomal DNA was isolated using PAXgene blood 
DNA kit (Qiagen, Venlo, Netherlands). C. albicans growth was 
measured every 10  min for 30  h by measuring absorbance at 
604 nm using the SOFTmax PRO software. The experiment was 
repeated five times.
elisa
Immobilization of NETs on 96-well plates and blocking was 
performed according to a modified protocol by Caudrillier et al. 
(23). Briefly, rabbit anti-human MPO antibodies (Sigma-Aldrich, 
Taufkirchen, Germany) (1:100) or rabbit anti-human histone 
H3 (citrulline R2 + R8 + R17) antibodies (Abcam, Cambridge, 
UK) (1:200) were coated onto 96-well plates overnight at 4°C. 
Blocking was performed with 5% BSA and 0.1% human serum 
albumin in DPBS. Isolated NETs were added and incubated at 
room temperature for 1 h. NHS- or C3-depleted sera or alterna-
tive pathway activated NHS (by addition of 10  mM EGTA) or 
complement inhibited NHS (by the addition of 10 mM EDTA) 
or purified FH (5–20  μg/ml) and/or C3b (20  µg/ml) (both 
Comptech., TX, USA) were added and incubated for 1 h at 37°C. 
FH and C3b were detected on the extracellular traps using goat 
anti-human FH or goat anti-human C3 antiserum (Comptech, 
TX, USA) (1:5,000) followed by rabbit anti-goat antibody/HRP 
(Dako, Hamburg, Germany) (1:5,000). The experiments were 
repeated three to five times.
Interleukin-1 beta (IL-1β) generation by monocytes was 
measured with IL-1β ready-set-go ELISA kit (eBioscience, 
Frankfurt, Germany) according to the manufacturer’s protocol. 
Blood-derived monocytes were incubated with similar amounts 
of isolated NETs in growth medium (also with 10% NHS) for 20 h 
and IL-1β was determined in the supernatants by the ELISA kit. 
The amount of IL-1β produced by monocytes in presence of NETs 
with FH (12.5 µg/ml) or together with C3b (12.5 µg/ml) was also 
determined. The experiment was repeated three times.
complement cofactor assay
Neutrophil extracellular traps were immobilized on a microtiter 
plate as described before (23) and incubated with C3b (20 µg/
ml) and FH (5–20 µg/ml) or NHS (10%) for 30 min at RT. After 
washing off unbound FH, C3b (10 µg/ml) and factor I (7 µg/ml) 
(Comptech, TX, USA) were added and incubated at 37°C for 1 h. 
The reaction was stopped with the addition of Roti-Load 1 (Carl 
Roth, Karlsruhe, Germany), and proteins were separated by SDS-
PAGE. C3b cleavage was assessed by Western blot analysis using 
goat complement C3 antiserum (Comptech, TX, USA) (1:1,000) 
followed by rabbit anti-goat antibody/HRP (1:2,500). The experi-
ment was repeated three times.
Mouse Model of Disseminated candidiasis
All animal experiments were conducted in compliance with 
European and German regulations. Protocols were approved 
by the responsible Federal State authority and ethics committee 
(Thüringer Landesamt für Verbraucherschutz, permit number: 
03-006/09). Female BALB/c mice (Charles River, Germany) 
weighing 18–20 g were housed in groups of five in individually 
ventilated cages with free access to water and food. For infec-
tion, C. albicans was grown for 12 h at 30°C in YPD medium, 
washed three times in sterile PBS, and diluted to the desired 
concentrations. The infection dose was confirmed by plating. On 
day 0, the mice were infected via the lateral tail vein with 2.5 × 104 
C. albicans cfu/g body weight. The health status of the mice was 
examined at least twice daily. Liver was collected 6 and 24 h post-
infection, fixed in 10% neutral buffered formalin (Histofix, Carl 
Roth, Karlsruhe, Germany), embedded in paraffin, and sectioned 
at 4 µm thickness.
immunohistochemistry of liver sections 
Derived from Mice with Disseminated 
candidiasis
Paraffin-embedded mice liver sections were deparrafinized by 
placing them consecutively in Roticlear (Carl Roth, Karlsruhe, 
Germany), 100% ethanol, and 95% ethanol. Sectioned tissues 
were boiled in 10  mM Na citrate buffer (pH 6.5) for antigen 
retrieval and blocked in 1% BSA supplemented PBS for 30 min. 
For the detection of CD115, Ly-6C, and Ly-6G in tissues from 
6  h post-infected mice, samples were treated with Alexa Fluor 
488 anti-mouse CD115 (CSF-1R) Antibody (1:100), Alexa Fluor 
700 anti-mouse Ly-6C Antibody (1:100), and Brilliant Violet 421 
FigUre 1 | continued.  
human blood-derived monocytes release Dna in response to 
Candida albicans. (a) Human blood monocytes (red) spontaneously engulf 
GFP-C. albicans cells (green). Representative cells from three independent 
experiments are shown. Pictures were taken with a LSM710 microscope 
(Zeiss), fitted with a 40×, 1.4 NA, oil-immersion lens, and processed, using 
ZEN 2011 software (Zeiss). Scale bar: 10 µm. (B) Representative example of 
gating strategy to determine by flow cytometry single- and double-positive 
monocytes (GFP and DID). (c) Phagocytosis of GFP-C. albicans is enhanced 
in complement active human serum (NHS). GFP-expressing C. albicans were 
incubated with monocytes in the absence or presence of human serum and 
the phagocytosis rate was determined by flow cytometry. Data represent 
mean values ± SDs of four independent experiments (Phagocytosis in NHS 
versus iNHS after 1 h **p = 0.0083; one sided Student’s t-test). 
(D) Peripheral blood monocytes react on GFP-C. albicans by the release of 
DNA, which was stained with SYTOX blue (upper panel). Release of DNA 
increased over time (lower panel) as measured by ZEN 2011 software (Zeiss). 
(e) Human blood monocytes phagocytose C. albicans cells, decondense 
after about 150 min the chromosomal DNA, and subsequently burst out the 
DNA. Blood monocytes were incubated with GFP-C. albicans cells at a ratio 
of 1:1 in the presence of 10% complement active human serum and 
interaction was followed by life time imaging using LSM (see also Video S1 in 
Supplementary Material). Red: DiD stained membrane, blue: SYTOX blue, 
green: GFP-Candida. (F) Both types of monocytes CD14++CD16− and 
CD14+CD16+ release DNA in response to C. albicans at about 150 min. 
Green: CD14, red: CD16, blue: SYTOX blue. Representative cells from at 
least three independent experiments. Pictures were taken with an LSM710 
microscope (Zeiss), fitted with a 40×, 1.4 NA, oil-immersion lens, and 
processed, using ZEN 2011 software (Zeiss). Size bars: 10 µm.
FigUre 1 | continued
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anti-mouse Ly-6G Antibody (1:100), respectively (all three anti-
bodies are from Biolegend, London, UK). About 0.1% saponin 
supplemented PBS was used to dilute antibodies, and SYTOX 
orange was used to detect DNA in the tissue samples. Alexa Fluor 
350 labeled anti-mouse FH antibody (1:1,000) (Bioss antibodies, 
MA, USA) diluted in 0.1% saponin supplemented PBS was used 
for detection of FH deposition in 24 h post-infected tissues and 
SYTOX green (5 µM) was used to detect DNA in the probes. Images 
were captured using LSM 710 with ZEN 2011 (401/421 nm for 
Alexa Fluor 350 and Brilliant Violet 421, 488/525 nm for Alexa 
Fluor 488, 504/523 nm for SYTOX green, 547/570 nm for SYTOX 
orange, and 679/702 nm for Alexa Fluor 700). The experiment 
was repeated three times.
statistical analysis
Significant differences between two groups were analyzed using 
the Student’s two-tailed t-test or one way ANOVA. Values of 
*p < 0.05, **p < 0.01, and ***p < 0.001 were considered statisti-
cally significant.
resUlTs
Monocytes Phagocytose C. albicans cells 
and release extracellular Dna
To follow the direct response of human monocytes to C. albicans 
in  vitro, live cell imaging was performed using laser scanning 
microscopy. Human monocytes were isolated from human blood 
using MACS (purity about 95% according to CD14 expres-
sion). These monocytes were incubated with GFP-expressing 
C. albicans at a ratio of 1:1 in growth medium with NHS in the 
presence of SYTOX blue, a nucleic acid dye that does not cross 
the intact cell wall membrane. Interaction of monocytes with 
C. albicans was followed over 12 h. Monocytes migrated toward 
the fungal pathogen and engulfed C. albicans cells within min-
utes (Figure 1A). Phagocytosis in 10% NHS, as evaluated by flow 
cytometry, was enhanced (about 30% after 15  min) compared 
with that in growth medium alone (Figures 1B,C).
Within the first minutes of contact with C. albicans, mono-
cytes were highly active and engulfed C. albicans cells. During 
the next 2–4  h of cultivation, several monocytes showed 
morphological changes. The nuclei enlarged, and faint stain-
ing of nuclear DNA appeared. This staining is explained by 
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increased membrane permeability and influx of the DNA dye 
SYTOX blue (Figures 1D,E). During the following 2 h, nuclear 
DNA decondensed and in several cases the DNA was suddenly 
released from the monocyte and appeared in the extracellular 
compartment around the ruptured membrane and on C. albicans 
(Video S1 in Supplementary Material; Figures 1D,E). In single 
cases, membrane rupture and release of extracellular DNA was 
detected even earlier, after 20–40 min. As cell remnants appeared 
in the medium, this type of DNA release resulted in monocyte 
cell death.
To compare this DNA release by monocytes with the previ-
ously described extracellular trap formation by neutrophils (24), 
the response of neutrophils to C. albicans was followed under 
identical experimental conditions. Neutrophils that were chal-
lenged with live C. albicans cells migrated toward the fungus, 
engulfed the pathogen, and also released the DNA in about the 
same time frame as monocytes (Figure S1 in Supplementary 
Material). Thus, both human innate immune cells, monocytes 
and neutrophils, release DNA within the first hours upon contact 
with C. albicans.
To determine whether release of DNA in response to 
C. albicans is specific to one subtype of monocytes or whether 
both types of monocytes (CD14++CD16−/CD14+CD16+) burst 
and release nuclear DNA, blood monocytes were again incubated 
with C. albicans in the presence of complement active human 
serum together with the DNA marker SYTOX blue. Monocytes 
were stained for CD14 and CD16 to allow identification of the 
specific subtype. Upon contact with C. albicans, both types of 
monocytes (CD14++CD16− and CD14+CD16+) released DNA 
within 2–3 h (Figure 1F).
Dna released by Monocytes captures  
C. albicans
Having shown that, upon contact with C. albicans, monocytes 
respond to the fungal pathogen by undergoing nuclear changes 
and releasing their DNA, the extracellular DNA was further 
characterized. Monocytes were cultivated with C. albicans in 
growth medium with 10% NHS for 4 h then fixed and stained 
for DNA with SYTOX and evaluated by microscopy. The released 
extracellular DNA appeared as fibrous structures, which were 
formed between several monocytes and C. albicans (Figure 2A). 
The extracellular DNA release was triggered by C. albicans but 
not after addition of WGP or LPS. To exclude DNA release of 
monocytes by piercing of C. albicans formed hyphae monocytes 
were also incubated with hyphae locked mutant C. albicans strain 
(cph1Δ/efg1Δ). Monocytes also formed extracellular DNA traps 
within 2–4 h coincubation with mutant C. albicans cells (Figure 
S2 in Supplementary Material). Upon DNase treatment, the 
extracellular traps disappeared, confirming DNA comprising the 
traps (Figure  2B). The shape and appearance of this extracel-
lular DNA was further determined by electron microscopy. The 
extracellular DNA released by monocytes (Figure  2C) formed 
cluster-like structures where groups of C. albicans were inter-
twined (Figure  2D). Furthermore, extracellular DNA formed 
dense nets, which were comprehensively deposited onto the sur-
face of C. albicans cells and hyphae (Figures 2E,F). In addition, 
bead-like structures appeared on the DNA strings (Figure 2G), 
which most likely represent multiple proteins. These extracellular 
DNA covered the fungal surfaces (Figure  2H). These results 
demonstrate that monocytes liberate DNA to form extracellular 
trap-like structures, which we call MoETs that immobilize C. 
albicans cells and hyphae.
Extracellular trap formation is originally described for neu-
trophils and represents a specific response of suicidal cell death, 
which is distinct from apoptosis (25). To rule out the possibility 
that monocytes undergo rapid apoptosis and secondary necrosis 
in response to C. albicans, cellular morphology was also studied 
in monocytes undergoing apoptosis. Upon induction of apopto-
sis, blebs appeared at around 2.5 h on the cell surface. In contrast 
to trap forming monocytes nuclear DNA condensed followed by 
secondary necrosis and extracellular DNA after 5 h (Figure S3 in 
Supplementary Material). In summary, DNA release by mono-
cytes via so-called MoETosis is a specific reaction by monocytes 
to combat microbes and is morphologically different to apoptosis.
Dna released by Monocytes  
contains MPO, elastase (e), citrullinated 
histone h3 (cit h3), lac, and Monocyte 
Marker cD14
In neutrophils, ROS trigger the dissociation of neutrophil elastase 
(NE) from a membrane-associated complex into the cytosol and 
activate its proteolytic activity in a MPO-dependent manner 
(26). NE is stored in azurophilic granules and contributes to 
antimicrobial activity in the phagosome. During NET formation, 
NE translocates from the granules to the nucleus and cleaves 
histones to promote chromatin decondensation. In this process, 
histone H3 becomes citrullinated and is liberated together with 
the DNA. To investigate whether MPO and elastase are active 
in MoETosis and whether histones are citrullinated in MoETs, 
extracellular DNA of monocytes was stained for serine protease 
elastase, MPO, and cit H3. MoETs were positively stained for all 
three proteins (Figures 3A–C). Similarly, MoETs were positively 
stained for LAC, a granule protein with antimicrobial activity 
(27) (Figure  3D). MPO, elastase, cit H3, and LAC within the 
extracellular traps covered the surface of C. albicans cells and 
hyphae. These results demonstrate that the DNA released from 
monocytes in response to C. albicans represents nuclear DNA 
and comprises antimicrobial proteins. Thus, the mechanism of 
MoETosis described here for monocytes is related to NETosis in 
neutrophils.
To clarify whether DNA release by monocytes is a specific 
reaction to C. albicans or a more general response to infectious 
microbes, monocytes were incubated with either the Gram-
positive bacterium S. aureus or the Gram-negative bacterium 
E.  coli. Using the same experimental setup as employed with 
C. albicans, monocytes were fixed after 4 h of incubation and DNA 
release was determined by laser scanning microscopy. Monocytes 
engulfed both the Gram-positive and Gram-negative bacteria and 
also released nuclear DNA (Figures 3E,F). Thus, human blood 
monocytes respond to the microbes C. albicans, S. aureus, and 
E. coli by spontaneous DNA release. Furthermore, the liberated 
DNA contained cit H3, a specific marker for extracellular traps.
FigUre 2 | released Dna in response to human monocytes traps Candida albicans. (a) DNA released by monocytes forms traps and immobilizes 
C. albicans, whereas whole glucan particles (WGP) or LPS have no effect. Blue: C. albicans, green: SYTOX green. (B) DNAse treatment leads to digestion and 
disappearance of DNA traps. Green: SYTOX green. Pictures in (a,B) were taken with an LSM710 microscope (Zeiss), fitted with 20× 1.4 NA lens or 40× 1.4 NA 
oil-immersion lens or 63× 1.4 NA oil-immersion lens, and processed, using ZEN 2011 software (Zeiss). Scale bar: 10 µm. Scanning electron microscopy of 
(c) blood monocytes alone after 4 h. Scale bar: 10 µm. (D,e) DNA fibers and nets that trap C. albicans cells and also hyphae. Scale bar: 10 µm. (F) Monocytic 
extracellular traps (MoETs) form dense structures that cover hyphae. Scale bar: 1 µm. (g) MoETs are covered with proteins and form strings with bead-like 
structures. Scale bar: 200 nm. (h) Magnification of MoETs demonstrates a dense network that covers C. albicans and damages the surface. Scale bars = 10 μm, 
1 µm, and 200 nm.
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To confirm monocyte origin of released DNA in response to 
C. albicans, monocytes and released DNA was stained for presence 
of CD14, a surface marker which is abundant on human mono-
cytes and much less expressed on human neutrophils (Figure 
S4 in Supplementary Material). The monocyte and the released 
DNA showed strong CD14 staining after 4  h of coincubation 
with C. albicans (Figure 4A), confirming the monocytic origin. 
In order to confirm DNA release by monocytes in vivo formalin-
fixed liver tissues from 6 h C. albicans-infected mice were stained 
with the monocytic markers CD115 and Ly6c, the granulocyte 
marker Ly6g and DNA stain SYTOX orange. Extracellular 
DNA was identified in the liver tissue which stained for CD115 
FigUre 4 | Monocytic extracellular traps stain positive for cD14, 
cD115, and ly6c. Extracellular traps derived from monocytes contain the 
monocytic marker (a) CD14. Human blood monocytes were incubated with 
Candida albicans (1:1) in growth medium with 10% NHS for 4 h, fixed, and 
stained with specific antibodies. Orange: SYTOX orange, green: CD14. 
(B) Mouse monocytes form extracellular traps (arrows) in mouse liver 
sections derived from C. albicans-infected mice. The traps show the 
monocytic markers CD115 and Ly6c, but not Ly6g, a marker for neutrophils. 
Representative stainings from at least three independent experiments are 
shown. Orange: DNA (SYTOX orange), green: CD115, red: Ly6c, blue: Ly6g. 
Pictures were taken with an LSM710 microscope (Zeiss), with 40× 1.4 NA 
oil-immersion lens or 100× 1.4 NA oil-immersion lens, and processed, using 
the ZEN 2011 software (Zeiss). Scale bar: 10 µm.
FigUre 3 | Monocytic extracellular traps stain positive for citrullinated 
histone (h3) myeloperoxidase (MPO), elastase (e), and lactoferrin 
(lac). Extracellular traps derived from monocytes contain (a) elastase, 
(B) MPO, (c) citrullinated H3 (cit-H3), and (D) LAC, which are known to 
harbor antimicrocidal activities. Human blood monocytes were incubated with 
Candida albicans (1:1) in 10% normal human serum for 4 h, fixed, and 
stained with specific antibodies for LS microscopy. Green: SYTOX green, red: 
citrullinated H3, or MPO, or elastase or lactoferrin as marked. (e) Monocytes 
incubated with Gram-positive (Staphylococcus aureus) or (F) Gram-negative 
(Escherichia coli) bacteria also form extracellular traps (green). Additionally, 
these traps contain citrullinated H3 (cit-H3, red). Representative cells from at 
least three independent experiments. Pictures were taken with an LSM710 
microscope (Zeiss), fitted with a 63×, 1.4 NA, oil-immersion lens, and 
processed, using ZEN 2011 software (Zeiss). Scale bar: 10 µm.
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and Ly6C (both markers for monocytes) and absence of Ly6G 
(marker for neutrophils) (Figure 4B). These data confirm  in vivo 
trap formation.
Monocytic extracellular Dna inhibits 
growth of C. albicans
Having shown that monocytes release DNA upon contact with the 
pathogenic fungus C. albicans, we asked whether this extracellu-
lar DNA affects pathogen survival. To this end, extracellular DNA 
released by monocytes upon incubation for 4 h with C. albicans 
was isolated. The isolated DNA and the associated proteins were 
separated by SDS-PAGE, proteins were immunoblotted, and the 
presence of cit H3 was assayed with anti-cit H3 antibodies. The 
antibody detected a specific band at 15 kDa, confirming the pres-
ence of cit H3 and MoETs (Figure 5A). cit H3 was not detected 
in human chromosomal DNA isolated by standard methods from 
THP-1 cells or from human blood monocytes. To test the anti-
fungal activity of the isolated MoETs, the isolated MoETs were 
added to C. albicans and fungal growth was followed over 30 h by 
assaying the optical density at 604 nm. Treatment with this iso-
lated extracellular trap DNA resulted in fungal growth inhibition. 
Fungal growth was reduced by about 45% after 6 h and by 35% 
after 24 h compared with C. albicans incubated in medium lack-
ing DNA or incubated with monocyte or THP-1 chromosomal 
DNA (Figure 5A). Thus, MoETs isolated from human monocytes 
have antifungal activity and reduce C. albicans growth.
FigUre 5 | extracellular Dna released by monocytes inhibits growth of Candida albicans. (a) Isolated monocytic extracellular traps (MoETs) stain for 
citrullinated H3 in Western blot analysis (left panel). Isolated MoETs kill C. albicans by about 45% after 12 h of coincubation (middle and right panel). In contrast, 
addition of chromosomal DNA derived from blood monocytes or THP-1 cells had no inhibitory effect on the growth rate of Candida. Data represent mean 
values ± SDs of five independent experiments (inhibition with MoETs versus no or chromosomal DNA, **p = 0.0067; two sided Student’s t-test). (B) Human 
monocytes release DNA in response to C. albicans, which is enhanced in complement active human serum. In comparison human neutrophils release less DNA in 
response to C. albicans. Data represent mean values ± SDs of four independent experiments [monocytes in normal human serum (NHS) versus iNHS **p = 0.0056, 
monocytes versus neutrophils in NHS **p = 0.0020; two sided Student’s t-test].
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MoeT Formation is enhanced in the 
Presence of active human serum
To determine the influence of serum factors on the extracellular 
trap formation, monocytes were incubated with C. albicans in 
10% NHS or heat-inactivated 10% NHS, the released extracellular 
DNA was stained with SYTOX green, and the amount of released 
DNA was determined every hour for a total of 5 h. Monocytes 
cocultivated with C. albicans in the presence of NHS and inac-
tive NHS released DNA into the medium, although presence of 
NHS aided the process. DNA release increased 5-fold after 1 h 
of incubation and 58-fold after 4 h of incubation compared with 
monocytes incubated in active serum but without C. albicans 
(Figure  5B). Neutrophils under the same conditions released 
11-fold more DNA after 4 h in active NHS than neutrophils in 
active serum without C. albicans, but released 70–80% less DNA 
in total than monocytes. DNA release by neutrophils did not 
significantly differ in active and inactive NHS (Figure  5B). In 
summary, when challenged with C. albicans, monocytes released 
fourfold more DNA into the medium than neutrophils.
extracellular Traps from Monocytes and 
neutrophils activate the complement 
system
To investigate whether MoETs activate complement in human 
serum, monocytes were incubated with C. albicans and active 
human serum. After incubation and immobilization on cover-
slips, the samples were stained with C3b and C5b–9 antibodies 
and investigated by laser scanning microscopy analysis. C3b 
and C5b–9 were deposited on MoETs as seen by colocalization 
of SYTOX green staining of the MoETS with C3b (Figure 6A) 
and C5b–9 (Figure 6B). Similarly, NETs showed C3b deposition 
(Figure 6C). To find out whether complement regulator FH recog-
nizes and binds C3b on the DNA, the traps were immunostained 
with FH antibodies. Both extracellular traps from monocytes and 
FigUre 6 | Deposition of complement proteins on extracellular traps. 
(a) Complement C3b and (B) complement C5b–9 are deposited on 
extracellular traps derived from monocytes (monocytic extracellular traps: 
MoETs) (c) or from neutrophils (neutrophil extracellular traps: NETs). Factor H 
(FH) binds to both (D) MoETs and (e) NETs. Human blood monocytes or 
neutrophils were incubated with Candida albicans (1:1) in 10% normal human 
serum for 4 h, fixed, and stained with the specific antibodies. Green: DNA, 
red: C3b, C5b–9, or FH. (F) Mouse FH binds to extracellular traps in mouse 
liver sections derived from C. albicans-infected mice. Sections were prepared 
24 h after infection with C. albicans. Blue: FH; green: DNA. Pictures were 
taken with a laser scanning microscope LSM 710 (Zeiss) and processed 
using ZEN 2011 software (Zeiss). Scale bar: 10 µm. Experiments were 
repeated three times and representative images are shown.
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neutrophils bound FH from the serum (Figures 6D,E) indicating 
restriction of complement activation by FH on the surfaces of 
the traps. Having shown that human extracellular DNA traps 
bind FH in  vitro, we aimed at identifying DNA traps with FH 
in tissue of C. albicans-infected mice. Therefore, ultra-thin sec-
tions of embedded liver derived from C. albicans-infected mice 
(24  h post-infection) were stained to detect DNA traps with 
FH. Extracellular DNA was identified in the sections which also 
stained with FH antibodies (Figure 6F). These results confirmed 
that FH bound to released nuclear DNA in the liver tissue.
To confirm in vitro binding of FH to the extracellular traps, 
NETs were isolated and immobilized to a microtiter plate via 
coated antibodies to citrullinated H3. The isolated immobilized 
NETs were incubated in NHS (10%) or with FH (10 µg/ml) and 
binding of FH was determined by ELISA. FH alone bound weakly 
to the NETs but attached to the NETs when recruited from NHS 
(Figure 7A). Complement inhibition by the addition of EDTA or 
EGTA to NHS substantially reduced FH binding to the NETs and 
suggested that FH was recruited by C3b to the NETs. Therefore, 
NETs were incubated in NHS activated via the alternative path-
way and this time stained for C3b binding. C3b deposited on the 
NETs and binding was blocked by adding the complement inhibi-
tor EDTA. Also, purified C3b bound to the NETs (Figure 7B). 
FH binding to the NETs from human serum was substantially 
reduced when NETs were incubated in C3-depleted serum com-
pared to NHS (Figure 7C). FH alone did not bind to the NETs but 
together with C3b FH bound in a dose-dependent manner. Thus, 
FH binding to NETs is mediated by deposited C3b. To determine 
whether bound FH on the NETs is active, cofactor activity of 
bound FH was followed by Western blot analysis. Again NETs 
were immobilized to the microtiter surface via anti-cit H3 and 
incubated with C3b and FH. After washing off the unbound FH 
and C3b, NETs were incubated with C3b and factor I. C3 cleavage 
fragments in the supernatant were then detected by Western blot 
analysis. NETs bound FH-mediated cleavage of C3b by factor I as 
seen by C3b cleavage products at 68, 46, and 43 kDa (Figure 7D). 
Similarly, C3b was cleaved to iC3b, when NETs were incubated 
with NHS. These results demonstrate that NETs bound FH is 
functionally active and can mediate complement cofactor activity.
Fh Bound to neTs inhibits a  
Pro-inflammatory cytokine response  
of Monocytes
Extracellular DNA traps often stay for a period of time in the 
blood before they are cleaved by DNase and are engulfed by 
phagocytes (28). Complement opsonization enhances the uptake 
of microbes and apoptotic cells by phagocytes (29). However, in 
contrast to microbes apoptotic self-cells do not induce the inflam-
masome and do not secrete inflammatory cytokines like IL-1β 
(30). Clearance of extracellular DNA traps by macrophages was 
previously shown not only to induce inflammatory cytokines (31) 
but also to act non-inflammatory (28). The presence of microbes, 
antimicrobial peptides, or microbial substances like LPS in the 
traps induces an inflammatory response in macrophages. Here, 
we isolated NETs from PMA induced neutrophils, incubated 
these NETs with human monocytes and IL-1β concentrations 
were determined after 20 h in the supernatants by ELISA. IL-1β 
production by PMA isolated with the NETs was excluded (Figure 
S5 in Supplementary Material). NETs induced the inflammasome 
in monocytes as determined by higher IL-1β concentrations in 
FigUre 7 | Factor h (Fh) bound to neutrophil extracellular traps (neTs) is functionally active and reduces inflammation induced by neTs. (a) FH in 
normal human serum (NHS) binds to immobilized NETs. This binding is dependent on complement activation, as FH alone or in complement inactive serum (EDTA) 
does not bind. Immobilized NETs were incubated in 10% serum + EGTA, 10% serum + EDTA, or purified Factor H (10 µg/ml). FH, factor H. (B) C3b binds directly to 
the NETs. C3b (20 µg/ml) was incubated with the purified immobilized NETs and detected with anti C3. (c) Purified FH (5–20 µg/ml) binds together with C3b (20 µg/
ml) to the NETs, but not alone. Factor H in NHS (10%) but not in C3-depleted NHS (10%) binds to the NETs. Data in (A–C) represent mean values ± SDs of three 
independent experiments (*p < 0.05, **p < 0.01, ***p < 0.001; two sided Student’s t-test). (D) FH bound to the NETs retains cofactor activity for factor I to cleave 
C3b. Western blot shows C3 cleavage products at 68, 46, and 43 kDa when NETs were incubated in 10% serum and also when factor H bound via C3b to the 
NETs and was incubated with C3b and factor I (FI) (lane 1–4). Incubation of NETs with FH alone before addition of C3b and FI shows no C3 cleavage bands (lane 5). 
NETs alone do not cleave C3b (lane 6). FH without NETs and incubated with C3b and FI results in cleavage of C3b (lane 7). Image is a representative result of three 
independent experiments. (e) Incubation of NETs with monocytes for 20 h induces interleukin-1 beta (IL-1β) secretion by isolated blood monocytes. FH bound by 
C3b on the NETs reduces the IL-1β secretion by monocytes. IL-1β level in the supernatant was measured by ELISA. Data represent mean values ± SDs of three 
independent experiments (*p < 0.05, one-way ANOVA).
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the supernatants compared to monocytes alone. Binding of FH 
via C3b on the NETs reduced IL-1β secretion in monocytes 
(Figure  7E). In contrast, FH alone added to the NHS did not 
modulate the IL-1β response in monocytes (data not shown). 
Altogether, the data demonstrate that binding of FH to NETs 
inhibits the inflammatory response of monocytes.
DiscUssiOn
The current study demonstrates that human blood monocytes 
before differentiating into macrophages release extracellular DNA 
upon interaction with C. albicans to trap and attack the fungus. 
Upon contact with C. albicans for 2–4 h, monocytes decondense 
their nuclear DNA and release the DNA, which forms MoETs that 
cover and fix C. albicans cells and hyphae. Characterizing these 
traps in detail revealed many similarities to NETs because MoETs 
contain cit H3, elastase, MPO, and LAC (32), which altogether 
have antifungal activity to restrict C. albicans dissemination. 
Monocytes also form MoETs in response to other microbes (e.g., 
E. coli and S. aureus); thus, trapping of microbes represents a 
direct immune reaction by monocytes. Extracellular traps acti-
vate complement and become opsonized with C3b. Complement 
regulator FH binds to opsonized traps and restricts complement 
activation and inflammation.
The current study aimed to shed light on how human 
monocytes react toward the pathogenic fungus C. albicans. 
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Live time imaging revealed that monocytes phagocytosed 
C. albicans cells and this process was followed by monocytic 
DNA release. The released DNA formed fiber-like structures 
that enwrapped C. albicans cells and hyphae, as shown by laser 
scanning microscopy as well as electron microscopy. Caspase 
1 inhibition in monocytes and subsequent incubation with 
C. albicans also resulted in MoETosis (data not shown) exclud-
ing DNA release by pyroptosis (33). Extracellular trap formation 
was first identified and described in neutrophils in response to 
microbes, and these traps are called NETs (34). During this 
process, chromatin decondensation leads to loss of the lobulated 
nucleus. Then, disintegration of intracellular membranes allows 
chromatin and extranuclear proteins to mix. The final step is the 
release of chromatin filaments decorated with proteins into the 
extracellular medium (25). The finding that human monocytes 
respond to C. albicans similar to neutrophils with the release of 
chromosomal DNA is new and supported by the observations 
that DNA release by monocytes was observed to E. coli (35) and 
to parasites Besnoitia besnoiti and Eimeria boxis (36). Besides 
neutrophils (24), eosinophils, mast cells, and macrophages also 
form extracellular traps (35, 37, 38). As shown here, in vivo trap 
formation thus represents a conserved immune reaction by 
immune cells toward microorganisms. However, MoET induc-
tion in monocytes is different to extracellular trap formation in 
macrophages, as DNA release in human monocytes cannot be 
triggered by cholesterol synthesis inhibitor simvastatin (data not 
shown) as previously reported for macrophages (39). Similar to 
METs (38) but in contrast to NETs, MoETs are not induced by 
LPS or PMA (latter not shown). Blocking the dectin receptor 
on monocytes by WGP also did not induce extracellular trap 
release. Thus, monocytes react specifically to microbes like 
C. albicans or E. coli by forming DNA traps.
The traps formed by monocytes contain cit H3. In neutrophils, 
citrullination of histone proteins is a crucial step in trap forma-
tion and is considered to be one of the markers of extracellular 
traps formed by neutrophils. Peptidylarginine deaminases cata-
lyze histone citrullination, where the positively charged arginine 
residues are converted into polar uncharged citrulline side chains 
by deamination (40, 41). Similar peptidylarginine deaminase 
activities are expected to catalyze the citrullination reaction in 
monocytes.
Antimicrobial molecules such as MPO and elastase, which are 
components of azurophilic granules in monocytes, were found 
in MoETs. These components together with released LAC seem 
to be responsible for the killing of C. albicans by MoETs (34). 
MoETosis identified and described in the current study repre-
sents an active immune response of monocytes to C. albicans, 
which leads to monocytic cell death. The process of extracellular 
trap formation in monocytes differs significantly from apoptosis. 
MoETosis started with intracellular vacuole formation, followed 
by loss of the nuclei lobular structure. Chromatin decondensed 
in the nucleus, expanded, and filled the intracellular space before 
being released into the extracellular space. During this process, 
the cells remained alive, as observed by the absence of PS expo-
sure on the plasma membrane (Figure S2 in Supplementary 
Material). Upon microbial contact, DNA was released within 
2–4 h. Similarly, NETosis by neutrophils was characterized as a 
new form of cell death with clearly different characteristics to the 
pathway characterized for apoptosis (25).
In contrast to MoETosis, bleb formation marks the start of 
apoptosis in monocytes after 4–6 h. Soon after bleb formation, 
the membrane flip-flops the inner leaflet of the plasma membrane 
exposing PS. When apoptotic cells are not cleared by phagocytes, 
the apoptotic process can lead to secondary necrosis. Secondary 
necrosis is observed after 9–12  h and is accompanied by cell 
enlargement and disintegration of nuclear material. Thus, apop-
tosis shows clear distinguishable morphological features from 
MoETosis in monocytes. Altogether, MoETosis represents an 
early coordinated process upon exposure to C. albicans or other 
pathogens. By contrast, apoptosis starts with bleb formation after 
about 4.5 h, followed by secondary necrosis about 10 h later.
Monocytes released approximately fivefold more DNA in 
response to C. albicans than neutrophils under the same condi-
tions. The higher amount of released DNA is to some degree 
explained by the counteraction of C. albicans. C. albicans follows 
several strategies to evade human immune attack (42–44). The 
most prominent evasion mechanism is the morphological switch 
to hyphal growth. With these hyphae, C. albicans can pierce 
through human cell membranes (45) and thus can also kill some 
monocytes during coincubation.
Altogether, the presented results highlight a prominent capac-
ity of monocytes to form extracellular traps against C. albicans 
to inhibit growth and dissemination of the fungus. This trap 
formation is in agreement with the observation that the absence 
of monocytes in mice has detrimental effects on fungal infec-
tions (15) and that depletion of mononuclear phagocytes results 
in accelerated fungal proliferation in tissues and in increased 
mortality (46). Therefore, trap formation by monocytes makes 
a significant contribution in hindering from very early on the 
propagation of an infection. Indeed, in the case of infections, 
monocytes are recruited from the bone marrow and the number 
of monocytes increases in blood. In addition, monocytes are 
recruited to infection sites in tissues and inhibit C. albicans 
growth both in vitro and in vivo (47).
Once extracellular traps are formed, these structures activate 
complement. This is in agreement with recent reports of NETs 
(48, 49) and suggested that complement is regulated on the 
NETs to allow opsonization and phagocytosis to terminate the 
immune response. Clearance of extracellular traps is achieved 
with the help of DNase I, which cleaves the extracellular DNA 
and facilitates uptake and clearance of DNA by macrophages (28). 
Here, we show that extracellular traps from both monocytes and 
neutrophils activate the complement system (50) and that FH 
binds to the DNA traps via C3b. Bound to NETs FH retains physi-
ological functions and exerts cofactor activity for the protease 
factor I to cleave C3b into iC3b. Furthermore, FH on the traps 
inhibits IL-1β secretion by monocytes. Thus, FH dampens the 
immune response to reduce the inflammatory response and to 
allow clearance of the traps.
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